TCT: PFO No Panacea for Migraine
WASHINGTON (MedPage Today) -- Percutaneous patent foramen ovale (PFO) closure did not significantly reduce the number of monthly migraine days compared with medical treatment, researchers reported here. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 17, 2014 Category: Cardiology Source Type: news

Transcranial Ultrasonography for PFO Screening?Transcranial Ultrasonography for PFO Screening?
Is non-invasive transcranial doppler a feasible alternative to more invasive and more costly transesophageal echocardiography for the detection of patent foramen ovale? Cardiovascular Ultrasound (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 21, 2014 Category: Consumer Health News Tags: Radiology Journal Article Source Type: news

Cardio Notes: Analysis Knocks PFO Closure
(MedPage Today) -- A meta-analysis confirms a previous one that found no benefit to patent foramen ovale closure versus medical therapy. Also, an ultrasound contrast agent is cleared of pulmonary hemodynamic effects. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 23, 2013 Category: Cardiology Source Type: news

Mixed Results for PFO Closure in Meta-Analysis (CME/CE)
(MedPage Today) -- Using a device for patent foramen ovale closure did not reduce recurrent events in patients with cryptogenic ischemic stroke, although there was a hint of benefit, a meta-analysis showed. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - August 20, 2013 Category: Cardiology Source Type: news

Patent Foramen Ovale Benefits From Transcatheter ClosurePatent Foramen Ovale Benefits From Transcatheter Closure
Transcatheter closure of patent foramen ovale (PFO) is superior to medical management for preventing recurrent vascular events, but not all closure devices are equal. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 17, 2013 Category: Consumer Health News Tags: Cardiology News Source Type: news

Percutaneous Patent Foramen Ovale Closure Impact on MigrainePercutaneous Patent Foramen Ovale Closure Impact on Migraine
Will randomized studies of patent foramen ovale closure in deep sea divers and others show reduction in migraine headaches, or is a turbo-placebo-effect taking place? Interventional Cardiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 28, 2013 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

RESPECT "device-in-place" analysis: Benefits of PFO closure?
A new post hoc "device-in-place" analysis of the RESPECT trial of patent foramen ovale closure in secondary stroke prevention has shown a magnification of benefits in comparison with the intention-to-treat or per-protocol analyses presented previously. (Source: theHeart.org)
Source: theHeart.org - June 26, 2013 Category: Cardiology Source Type: news

RESPECT 'Device in Place' Analysis: Benefits of PFO Closure?RESPECT 'Device in Place' Analysis: Benefits of PFO Closure?
A new post hoc 'device in place' analysis of the RESPECT trial of patent foramen ovale closure in secondary stroke prevention has shown a magnification of benefits compared with the intention-to-treat or per-protocol analyses presented previously. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 26, 2013 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Heart Defect Closure Rate Increasing (CME/CE)
ORLANDO (MedPage Today) -- The number of procedures performed to close an atrial septal defect or patent foramen ovale has increased in recent years, while length of stay associated with the procedure has dropped, researchers found. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - May 9, 2013 Category: Cardiology Source Type: news

PFO Stroke Risk May Be Overstated (CME/CE)
(MedPage Today) -- Among healthy older adults who were followed for more than a decade, the presence of a patent foramen ovale (PFO) was not associated with ischemic stroke or subclinical cerebrovascular disease, researchers found. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - May 1, 2013 Category: Cardiology Source Type: news

Patent foramen ovale closure debate still smolders
Two randomized controlled trials in The New England Journal of Medicine fail to prove that closing a patent foramen ovale can reduce risk for recurrent cryptogenic stroke. (Source: MedWire News - Cardiology)
Source: MedWire News - Cardiology - March 25, 2013 Category: Cardiology Source Type: news

The Best Option for Preventing Cryptogenic Embolism
(Ivanhoe Newswire) -- Past studies have shown an association of cryptogenic stroke and embolism with patent foramen ovale (PFO). However, the question of how to prevent it in patients remains unanswered. Now, recent research is investigating whether percutaneous closure or antithrombotic medications are superior. (Source: Medical Headlines From Ivanhoe.com)
Source: Medical Headlines From Ivanhoe.com - March 25, 2013 Category: Consumer Health News Source Type: news

PFO Closure Still an Open Question (CME/CE)
(MedPage Today) -- The negative results of three randomized trials should have closed the book on patent foramen ovale closure in cryptogenic stroke, but the book is still being read. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 20, 2013 Category: Cardiology Source Type: news

RESPECT and PC Trial published: Results of PFO closure debated again
The randomized, controlled clinical trials both missed their primary end points, findings that disappointed many hoping that closure of patent foramen ovale with the Amplatzer occluder would prevent stroke recurrence in patients who previously had a cryptogenic stroke. The results, however, are still being debated among those in the clinical community. (Source: theHeart.org)
Source: theHeart.org - March 20, 2013 Category: Cardiology Source Type: news

Data from St. Jude Medical RESPECT Trial for PFO Closure Highlighted at International Stroke Conference 2013
Presentation of neurological data confirms patients in the device group had fewer, smaller strokes that were less likely to originate from blood clots passing through the PFO ST. PAUL, Minn.--(Healthcare Sales & Marketing Network)--St. Jude Medical, Inc... Devices, Interventional CardiologySt. Jude Medical, patent foramen ovale, AMPLATZER, AMPLATZER PFO Occluder (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 8, 2013 Category: Pharmaceuticals Source Type: news

The RESPECT TrialThe RESPECT Trial
What are the pros and cons of patent foramen ovale closure, when compared to medical management? The Journal of Invasive Cardiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 28, 2013 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Patent Foramen Ovale and Paradoxical Stroke in a Young Cyclist
Most patients with PFO remain asymptomatic because under normal physiologic conditions, a small amount of left-to-right shunting occurs without causing significant hemodynamic change. Here, a case in point. (Source: Consultant Live)
Source: Consultant Live - January 25, 2013 Category: Primary Care Source Type: news